Patent Assignment
Reel/Frame 039032/0303
Assignment of Assignor's Interest
Recorded: 2016-06-28
Pages: 10
Assignor
TABUTEAU, HERRIOT
Executed: 2016-06-14
Assignee
ANTICEP BIOVENTURES II LLC
630 FIFTH AVENUE, SUITE 2000, NEW YORK, NEW YORK, 10111
Covered Properties
(14)
Pharmacodynamic Effects After Oral Administration of Zoledronic Acid or Related Compounds
Application:
62/150,871 →
Pharmaceutical Compositions Comprising Meloxicam
Application:
62/259,993 →
Methods of Modulating Drug Plasma Levels Using Bupropion
Application:
62/313,067 →
Methods of Modulating Drug Plasma Levels Using Bupropion
Application:
62/313,620 →
Methods of Modulating Drug Plasma Levels Using Bupropion
Application:
62/323,438 →
Methods of Modulating Drug Plasma Levels
Application:
62/336,533 →
Implantable Polymeric Device for Sustained Release of Sufentanil
Application:
13/468,215 →
Publication:
US US20120288551A1
Compositions and Methods Comprising Tilidine or Related Compounds and Dextromethorphan
Patent:
8,569,328 →
Application:
13/478,023 →
Compositions and Methods Comprising Celecoxib or Related Compounds and Dextromethorphan
Application:
13/857,017 →
Publication:
US US20130274282A1
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
Application:
13/894,244 →
Publication:
US US20130303485A1
Compositions Comprising Zoledronic Acid or Related Compounds for Relieving Pain Associated with Arthritis
Application:
13/894,252 →
Publication:
US US20130303486A1
Compositions Comprising Zoledronic Acid or Related Compounds for Relieving Inflammatory Pain and Related Conditions
Application:
13/894,262 →
Publication:
US US20130303487A1
Compositions Comprising Zoledronic Acid or Related Compounds for Treatment of Complex Regional Pain Syndrome
Application:
13/894,274 →
Publication:
US US20130303488A1
Compositions and Methods Comprising Celecoxib or Related Compounds and Dextromethorphan
Application:
13/943,729 →
Publication:
US US20140051718A1
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 10, 2012
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 028187/0291 →
Assignment of Assignor's Interest
Jun 20, 2012
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 028413/0609 →
Assignment of Assignor's Interest
Feb 17, 2014
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 032228/0956 →
Corrective Assignment to Correct the Spelling of the Receiving Party Name Previously Recorded on Reel 039032 Frame 0303. Assignor(S) Hereby Confirms the Assignment.
Jul 19, 2016
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 039391/0667 →
Assignment of Assignor's Interest
Sep 21, 2017
From: ANTECIP BIOVENTURES II LLC
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 043657/0690 →
Assignment of Assignor's Interest
Dec 8, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 044343/0372 →
Assignment of Assignor's Interest
Dec 8, 2017
From: TABUTEAU, HERRIOT
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 044343/0453 →
Security Interest
May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →